Inspired By Research.
Centered Around People.
Rooted In Technology.

Aiberry’s technology is based on two decades of research led by our Chief Scientist and co-founder, Dr. Newton Howard. A fateful personal experience led him down a path committed to improving mental healthcare through technology, and his work is the backbone of Aiberry’s solution.

A Personal Experience

A Commitment To Improving Mental Healthcare

“Through my personal and professional experience, I have seen firsthand that our brain and neural systems are capable of incredible powers that have yet to be discovered or fully understood.

My journey into the field of neurosciences and mental health began after years of active duty in the United States Army. While overseas on a special assignment, the vehicle I was traveling in ran over an IED. As a result of this blast, I developed a traumatic brain injury (TBI) and quickly saw firsthand how poor mental health treatment and care options were. It was at this moment that I decided to dedicate my professional efforts to brain science and mental health. I refocused my research on psychiatry, neuroscience, and artificial intelligence with the goal of gaining a deeper understanding of the human brain and novel treatments using technology.”

- Dr. Newton Howard

A Deeper Look At The Research

Since finding his calling, Dr. Howard has collaborated with top researchers across the world and pushed our understanding of cognitive neuroscience and computational systems to a new level. Throughout his career, he has published over 183 patents and written more than 300 articles in the field of AI. While at the Department of Mathematical Sciences at the University of Oxford in 2000, Dr. Howard proposed the Theory of Intention Awareness, which is one of the cornerstones for the science behind Aiberry’s solution. 

Aiberry’s Groundbreaking Clinical Study

Aiberry’s AI tools and technology are held to the same rigorous standards as research clinicians to ensure the efficacy of our platform. We are currently conducting an ongoing clinical study with leading healthcare providers and academic institutions to train and validate Aiberry’s Mental Health Screening Platform in patients between the ages of 13 and 79.